Targeting EML4-ALK driven non-small cell lung cancer (NSCLC)

類似資料

• The epidermal growth factor receptor (EGRF) in lung cancer
  著者:: Carcereny, Enric, 等
  出版事項: (2015)
• EML4-ALK V3, treatment resistance, and survival: refining the diagnosis of ALK(+) NSCLC
  著者:: Christopoulos, Petros, 等
  出版事項: (2018)
• Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion
  著者:: Aguado, Cristina, 等
  出版事項: (2018)
• Concordance of IHC, FISH and RT-PCR for EML4-ALK rearrangements
  著者:: Teixidó, Cristina, 等
  出版事項: (2014)
• Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs
  著者:: Bayliss, Richard, 等
  出版事項: (2016)